Onconova Presents Positive Data rom Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at #ASH2015
December 07, 2015 at 19:21 PM EST
Onconova Therapeutics, Inc. (NASDAQ: ONTX) today announced the presentation of data from an ongoing Phase 1/2 clinical trial of oral ...